Does Vascepa Have a Patient Savings Program?
Yes, Vascepa (icosapent ethyl) offers the Vascepa Savings Program for commercially insured patients. Eligible patients pay as little as $9 per 30- to 90-day prescription supply, with a maximum annual savings of $16,200. No income restrictions apply, but government beneficiaries like Medicare patients are ineligible.[1]
Who Qualifies and How to Enroll?
Commercial insurance is required; the program covers copays, deductibles, and out-of-pocket costs after insurance. Patients activate it by texting "START" to 91830 or visiting the official Vascepa Savings Card page. A pharmacy can also process it with the card details.[1]
What If You're Uninsured or Underinsured?
Uninsured patients do not qualify for the savings card. Instead, options include patient assistance programs like the Vascepa Patient Assistance Program through Amarin or general pharmaceutical aid via organizations such as PAN Foundation or NeedyMeds. Check eligibility based on income and residency.[2][3]
How Does It Compare to Other Omega-3 Drug Savings?
Vascepa's program is more generous than some competitors like Lovaza (no dedicated card) or generic fish oils (often cash-pay only). For example, Epanova's savings caps at $150/month, while Vascepa's extends higher limits.[1][4]
Patent Status and Generic Availability
Vascepa's key patents expire in 2031 in the U.S., delaying generics. No biosimilars or approved generics exist yet, keeping reliance on branded savings programs high. For updates, see DrugPatentWatch.com.[5]